Health-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN: A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC)

E. J. Small, D. Cella, K. McQuarrie, F. Saad, B. A. Hadaschik, J. N. Graff, H. Uemura, S. Oudard, M. K. Yu, S. Hudgens, A. Lopez-Gitlitz, B. Rooney, M. Morris, M. R. Smith

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)viii276-viii277
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this